5,050.00
0.00
(0.00%)
As of April 8 at 11:15:13 AM CST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 30 | 30 |
| Avg. Estimate | 1.61B | 1.7B | 6.94B | 7.72B |
| Low Estimate | 1.6B | 1.68B | 6.86B | 7.49B |
| High Estimate | 1.61B | 1.72B | 6.98B | 8.03B |
| Year Ago Sales | 1.42B | 1.5B | 6.13B | 6.94B |
| Sales Growth (year/est) | 13.39% | 13.15% | 13.12% | 11.24% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ADSK.MX | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | JP Morgan: Neutral to Neutral | 4/9/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 4/8/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 3/17/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/28/2025 |
| Maintains | UBS: Buy to Buy | 2/28/2025 |
| Maintains | Stifel: Buy to Buy | 2/28/2025 |